These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34716874)

  • 1. Is minimally invasive surgery for clinical stage I uterine carcinosarcoma safe?
    Sinha R; Nizam A; Shan W; Shih KK; Frimer M; Sakaris A; Goldberg GL
    J Robot Surg; 2022 Aug; 16(4):943-949. PubMed ID: 34716874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study.
    Corrado G; Ciccarone F; Cosentino F; Legge F; Rosati A; Arcieri M; Turco LC; Certelli C; Federico A; Vizza E; Fanfani F; Scambia G; Ferrandina G
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):845-852. PubMed ID: 32880752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma.
    Pedra Nobre S; Mueller JJ; Gardner GJ; Long Roche K; Brown CL; Soslow RA; Alektiar KM; Sonoda Y; Broach VA; Jewell EL; Zivanovic O; Chi DS; Abu-Rustum NR; Leitao MM
    Int J Gynecol Cancer; 2020 Aug; 30(8):1162-1168. PubMed ID: 32690592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer.
    Zhou ZN; Chen L; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Hershman DL; Wright JD
    Gynecol Oncol; 2022 Feb; 164(2):341-347. PubMed ID: 34920885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.
    Matsuo K; Johnson MS; Im DD; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Klobocista MM; Hasegawa K; Ueda Y; Shida M; Baba T; Satoh S; Yokoyama T; Machida H; Ikeda Y; Adachi S; Miyake TM; Iwasaki K; Yanai S; Takeuchi S; Nishimura M; Nagano T; Takekuma M; Shahzad MMK; Pejovic T; Omatsu K; Kelley JL; Ueland FR; Roman LD
    J Surg Oncol; 2018 Mar; 117(3):488-496. PubMed ID: 29044542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Gynecol Oncol; 2016 Jun; 141(3):447-453. PubMed ID: 27072806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine carcinosarcoma: A review of the literature.
    Cantrell LA; Blank SV; Duska LR
    Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer.
    Segarra-Vidal B; Dinoi G; Zorrilla-Vaca A; Mariani A; Student V; Garcia NA; Llueca Abella A; Ramirez PT
    Obstet Gynecol; 2021 Dec; 138(6):828-837. PubMed ID: 34735382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes.
    Brandt B; Sioulas V; Basaran D; Kuhn T; LaVigne K; Gardner GJ; Sonoda Y; Chi DS; Long Roche KC; Mueller JJ; Jewell EL; Broach VA; Zivanovic O; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Mar; 156(3):591-597. PubMed ID: 31918996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.
    Matsuo K; Omatsu K; Ross MS; Johnson MS; Yunokawa M; Klobocista MM; Im DD; Bush SH; Ueda Y; Takano T; Blake EA; Hasegawa K; Baba T; Shida M; Satoh S; Yokoyama T; Machida H; Adachi S; Ikeda Y; Iwasaki K; Miyake TM; Yanai S; Nishimura M; Nagano T; Takekuma M; Takeuchi S; Pejovic T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
    Gynecol Oncol; 2017 Apr; 145(1):78-87. PubMed ID: 28215838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
    Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
    Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage ≥ II: A retrospective study.
    Perri T; Levin G; Helpman L; Eitan R; Vaknin Z; Lavie O; Ben Arie A; Amit A; Levy T; Namazov A; Ben Shachar I; Atlas I; Bruchim I; Kogan L; Gemer O
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():43-47. PubMed ID: 34800816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy improves overall survival when added to surgery and chemotherapy for uterine carcinosarcoma: a surveillance, epidemiology, and end results analysis.
    Squires BS; Quinn TJ; Nandalur SR; Jawad MS
    Int J Clin Oncol; 2021 Dec; 26(12):2282-2294. PubMed ID: 34427803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?
    Güngördük K; Plett H; Gülseren V; Meydanlı M; Boyraz G; Özdemir İ; Şahin H; Şenol T; Yıldırım N; Turan T; Öge T; Gökçü M; Taşkın S; Ayhan A; Ataseven B
    Oncol Res Treat; 2021; 44(1-2):43-51. PubMed ID: 33249415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma.
    Elshaikh MA; Modh A; Jhingran A; Biagioli MC; Coleman RL; Gaffney DK; Harkenrider MM; Heskett K; Jolly S; Kidd E; Lee LJ; Li L; Portelance L; Sherertz T; Venkatessan AM; Wahl AO; Yashar CM; Small W
    Gynecol Oncol; 2020 Aug; 158(2):460-466. PubMed ID: 32475772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
    Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
    Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.